TrialPloS one2014

Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study.

Lisanne L Krens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.